BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17672898)

  • 1. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
    Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
    World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
    Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
    Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
    Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
    Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
    Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
    Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype.
    Wågsater D; Mumtaz M; Lofgren S; Hugander A; Dimberg J
    Cancer Invest; 2008 Dec; 26(10):1008-14. PubMed ID: 18798067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression of the chemokine, CCL28, in human colorectal cancer.
    Dimberg J; Hugander A; Wågsäter D
    Int J Oncol; 2006 Feb; 28(2):315-9. PubMed ID: 16391784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the eotaxin gene -426C-->T, -384A-->G and 67G-->a single-nucleotide polymorphisms and atopic dermatitis in Italian children using family-based association methods.
    Rigoli L; Caminiti L; Di Bella C; Procopio V; Cuppari C; Vita D; Barberio G; Salpietro C; Pajno GB
    Clin Exp Dermatol; 2008 May; 33(3):316-21. PubMed ID: 18312459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
    Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
    Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-17 in human colorectal cancer.
    Wägsäter D; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2006; 26(6B):4213-6. PubMed ID: 17201135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.
    Antonacopoulou AG; Palli M; Marousi S; Dimitrakopoulos FI; Kyriakopoulou U; Tsamandas AC; Scopa CD; Papavassiliou AG; Kalofonos HP
    Mol Carcinog; 2010 Jul; 49(7):693-9. PubMed ID: 20564346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
    Viet HT; Wågsäter D; Hugander A; Dimberg J
    Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels.
    Batra J; Rajpoot R; Ahluwalia J; Devarapu SK; Sharma SK; Dinda AK; Ghosh B
    J Med Genet; 2007 Jun; 44(6):397-403. PubMed ID: 17220216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
    Kouhkan F; Motovali-Bashi M; Hojati Z
    Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
    Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
    Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.